Harvey JM, Clark GM, Osborne CK, Allred DC, et al. Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer. J Clin Oncol 2023;41:1331-1338.
PMID: 36827742